Wenjuan Ma Selected Research

Breast Neoplasms (Breast Cancer)

10/2023	Predictive value of radiomic signature based on 2-[18F]FDG PET/CT in HER2 status determination for primary breast cancer with equivocal IHC results.
3/2023	Clinicomics-guided distant metastasis prediction in breast cancer via artificial intelligence.
11/2022	Biomimetic Nanoerythrosome-Coated Aptamer-DNA Tetrahedron/Maytansine Conjugates: pH-Responsive and Targeted Cytotoxicity for HER2-Positive Breast Cancer.
1/2021	Molecular subtype classification of breast cancer using established radiomic signature models based on 18F-FDG PET/CT images.
10/2019	An Intelligent DNA Nanorobot with in Vitro Enhanced Protein Lysosomal Degradation of HER2.
5/2019	DNA-Based Nanomedicine with Targeting and Enhancement of Therapeutic Efficacy of Breast Cancer Cells.
12/2017	Fluorescence quenching-based signal amplification on immunochromatography test strips for dual-mode sensing of two biomarkers of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenjuan Ma Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 10/2013
7	Breast Neoplasms (Breast Cancer) 10/2023 - 12/2017
6	Neoplasm Metastasis (Metastasis) 03/2023 - 01/2019
4	Nasopharyngeal Carcinoma 03/2024 - 08/2021
4	Inflammation (Inflammations) 04/2023 - 10/2021
4	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 12/2017
4	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 07/2018
4	Leukemia 01/2020 - 10/2013
3	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 01/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 07/2023
2	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 01/2023
2	Osteoporosis 01/2024 - 01/2018
2	Bone Diseases (Bone Disease) 08/2023 - 01/2018
2	Epilepsy (Aura) 06/2023 - 01/2022
2	Wounds and Injuries (Trauma) 01/2023 - 01/2020
2	Lymphatic Metastasis 01/2023 - 09/2020
2	Rectal Neoplasms (Rectal Cancer) 12/2022 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 10/2015
2	Carcinogenesis 07/2022 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2018
1	Glucose Metabolism Disorders 01/2024
1	Neuroinflammatory Diseases 10/2023
1	Temporal Lobe Epilepsy 06/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Acute-Phase Reaction 01/2023
1	Constipation 11/2022
1	Pruritus (Itching) 11/2022
1	Hepatocellular Carcinoma (Hepatoma) 11/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2022
1	Paralysis (Palsy) 10/2022
1	Hypersensitivity (Allergy) 10/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2022

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2015
9	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 10/2017
7	Nucleic AcidsIBA 08/2023 - 01/2020
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2017
4	A-Form DNA (A-DNA)IBA 01/2024 - 05/2019
3	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2019
2	Nucleotide AptamersIBA 09/2023 - 11/2022
2	MicroRNAs (MicroRNA)IBA 08/2023 - 11/2015
2	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2019
2	Therapeutic UsesIBA 06/2021 - 01/2020
2	AntigensIBA 03/2021 - 12/2017
2	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 11/2015
2	Heterogeneous-Nuclear Ribonucleoprotein DIBA 01/2020 - 09/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 02/2019
2	NucleolinIBA 05/2019 - 10/2017
2	AGRO 100IBA 05/2019 - 10/2017
2	Carcinoembryonic AntigenIBA 03/2019 - 12/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 07/2018
2	baysilon (polydimethylsiloxane)IBA 06/2018 - 01/2018
2	Long Noncoding RNAIBA 12/2017 - 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2024
1	Gemcitabine FDA Link 03/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2024
1	berberrubineIBA 01/2024
1	BerberineIBA 01/2024
1	Chlorogenic AcidIBA 01/2024
1	demethyleneberberineIBA 01/2024
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 01/2024
1	swertiamarinIBA 01/2024
1	CurcuminIBA 01/2024
1	LisaftoclaxIBA 12/2023
1	Epoxide HydrolasesIBA 10/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2023
1	human ERBB2 proteinIBA 10/2023
1	Immunoconjugates (Immunoconjugate)IBA 09/2023
1	Interleukin-2 (IL2)IBA 07/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2023
1	Adenosine (Adenocard)FDA LinkGeneric 06/2023
1	Caspase 3 (Caspase-3)IBA 04/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2023
1	ProteomeIBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	typhaneosideIBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2022
1	Aprepitant (Emend)FDA Link 11/2022
1	desloratadine (Aerius)FDA LinkGeneric 11/2022
1	Tyrosine Kinase InhibitorsIBA 11/2022
1	Liposomes (Liposome)IBA 11/2022
1	Maytansine (Maitansine)IBA 11/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 11/2022
1	GinsenosidesIBA 10/2022
1	Serotonin (5 Hydroxytryptamine)IBA 10/2022
1	Indicators and Reagents (Reagents)IBA 07/2022
1	Nylons (Nylon)IBA 07/2022
1	Etoposide (VP 16)FDA LinkGeneric 07/2022
1	Chlorambucil (Leukeran)FDA Link 07/2022

Therapy/Procedure

20	Therapeutics 05/2024 - 04/2014
9	Drug Therapy (Chemotherapy) 01/2024 - 01/2018
5	Immunotherapy 12/2023 - 01/2017
1	Precision Medicine 01/2023
1	Neoadjuvant Therapy 01/2023
1	Radiotherapy 12/2022